6Kononen J,Bubendorf L,Kallionieni A,et al.Tissue nicroarrays for high-throughput molecular profiling of tumor specimens[J].Nature Med,1998,4 (7):844
7Bubendorf L,Kononen J,Koivisto P,et al.Survery of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays[J].Cancer Res,1999,59:803
9Hoos A,Urist MJ,Stojadinovic A,et al.Validation of tissue microarrays for immunohistoehemical profiling of cancer speciments using the example of human fibroblastic tumors[J].Am J Pathol,2001,158 (4):1245
1[1]Kononen J, Bubendor L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998,4(7):844～7.
2[2]Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists in categoriz ductal carcinoma in situ of the breast using five classifications. European commission working group on breast screening pathology. Hum Pathol, 1998,29(10):1056～62.
3[3]Barlund M, Forozan F, Kononen J, et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst, 2000,92(15):1252～9.
4[4]Camp RL, Charette LA, Rimm DL, et al. Validation of tissue microarray technology in breast carcinoma. Lab Inves, 2000,80(12):1943～9.
5[5]Jacobs TW, Pliss N, Kouria G, et al. Carcinoma in situ of the breast with indeterminate features. Role of E-Cadherin staining in categorization. Am J Surg Pathol, 2001,25(2):229～36.
6[6]Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast. Role of associated lesions and E-Cadherin in differential diagnosis. Am J Surg Pathol, 2001,25(2):237～44.
7[7]Elzagheid A, Kuopio T, Ilmen M, et al. Prognostication of invasive ductal breast cancer by quantification of E-cad immunostaining: the methodology and clinical relevance. Histopathology, 2002,41:127～33.
8[10]Zwelling LA. Characterization of an amsacrine-resisant line of human leukemia cells evidence for a drug-resistant from of topoisomerase Ⅱ. J Biol Chem, 1998,264:16411～22.
9[1]Kononen J,Bubendorf L,Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens.Nat Med,1998,4:844
4Roger Prichard, Andy Tait. The Role of Molecular Biology in Beterinary Parasitology [ J ]. Veterinary Parasitology,2001,98 (1-3): 169-194.
5David P Knox, Diane L Redmond, Philip J Skuce, et al. The Contribution of Molecular Biology to the Development of Vaccines Against Nematode and Trematode Parasites of Domestic Ruminants[J]. Veterinary Parasitology, 2001,101 (3 -4) : 311 -335 .
6Paul T Monis, Steven Giglio, Alexandra R Keegan,et al. Emerging Technologies for the Detection and Genetic Characterization of Protozoan Parasites[J]. Trends in Parasitology, 2005,21 ( 7 ) : 340 - 346.
7John C Boothroyd, Ira Blader, Michael Cleary, et al. DNA Mieroarrays in Parasitology : Strengths and Limitations [ J ]. Trends in Parasitology, 2003, 19(10) : 470-476.
8David P Knox, Philip J Skuce. SAGE and the Quantitative Analysis of Gene Expression in Parasites [ J ]. Trends in Parasitology, 2005,21 ( 7 ) : 322 - 326.
9John PAckers, David Mirelman. Progress in Research on Entamoeba Histolytica Pathogenesis [ J ]. Current Opinion in Microbiology, 2006,9(4) :367 - 373.
10Michel K, Kafatos FC. Mosquito Immunity Against Plasmodium[J]. Insect Biochemistry and Molecular Biology, 2005, 35 (7) : 677 - 689.
